[144] BrightSpring Health Services, Inc. SEC Filing

Rhea-AI Filing Summary

BrightSpring Health Services (BTSG) reported a Form 144 notice declaring a proposed sale of 16,168 common shares through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $362,240.87, scheduled approximately for 08/14/2025. The filing shows the shares arose from two acquisitions: 9,945 shares from restricted stock vesting on 01/25/2025 (compensation) and 6,223 shares from an option exercise dated 08/14/2025 (cash). The filer reports 177,148,693 shares outstanding and notes no sales by the filer in the past three months.

Positive

• Transparent compliance with Rule 144 reporting by disclosing the planned sale and acquisition details
• Clear provenance of shares: 9,945 from restricted stock vesting (compensation) and 6,223 from an option transaction

Negative

• Proposed insider sale of 16,168 shares valued at $362,240.87 could be perceived negatively by some investors
• Sale timing includes an option-related transaction dated the same day as the planned sale (08/14/2025), which may attract market attention

Insights

Financial Analyst

TL;DR: Routine insider sale notice for vested restricted stock and option shares; not immediately material absent other disclosures.

The Form 144 documents a proposed sale of 16,168 common shares valued at $362,241 via Fidelity on NASDAQ, arising from recent restricted stock vesting and an option-related transaction. The filing complies with Rule 144 disclosure requirements and shows no prior sales in the last three months. Without accompanying earnings, guidance, or additional insider transactions, this single notice is a disclosure of intent to sell rather than evidence of company-wide financial stress or clear insider signaling.

Corporate Governance Expert

TL;DR: Insider is following required procedures to disclose intended sale; documentation of compensation-related share vesting is transparent.

The notice transparently ties the shares to compensation (restricted stock vesting) and an option exercise, including acquisition and payment dates. It affirms the filer does not possess undisclosed material adverse information. From a governance perspective, timely Rule 144 filings and explicit source-of-acquisition entries are best practice and support regulatory compliance. The filing itself does not reveal changes to governance or management roles.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	16168	362240.87	177148693	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/25/2025	Restricted Stock Vesting	Issuer			9945	01/25/2025	Compensation
Common	08/14/2025	Option Granted - 01/25/2024	Issuer			6223	08/14/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did BrightSpring (BTSG) disclose in this Form 144?

The filer disclosed a proposed sale of 16,168 common shares via Fidelity on NASDAQ with an aggregate value of $362,240.87, planned for 08/14/2025.

Where did the shares being sold come from?

The shares derive from two acquisitions: 9,945 shares from restricted stock vesting on 01/25/2025 (compensation) and 6,223 shares from an option-related transaction (option granted 01/25/2024) with payment on 08/14/2025.

Does the filing report recent sales by the filer in the past three months?

No. The Form 144 lists "Nothing to Report" under securities sold during the past three months.

Which broker and exchange are involved in the proposed sale?

The sale is to be executed through Fidelity Brokerage Services LLC and listed on NASDAQ.

How many shares outstanding did the filing list?

The filing reports 177,148,693 shares outstanding.